Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes.

Saved in:
Bibliographic Details
Title: Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes.
Authors: Liu, Xiangxiang1 (AUTHOR), Ping, Guoqiang2 (AUTHOR), Ji, Dongze2 (AUTHOR), Wen, Zhifa1 (AUTHOR), Chen, Yajun1 (AUTHOR) Yajunchen_doctor@163.com
Source: Biomedical Engineering & Computational Biology. 8/30/2024, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11795972
DOI:10.1177/11795972241274024